85778-54-7

Usage

Uses

Used in Pharmaceutical Industry:
3-OXO-3-(4-PHENOXYPHENYL)PROPIONIC ACID METHYL ESTER is used as a potential therapeutic agent for the treatment of inflammatory disorders such as arthritis and joint pain. Its anti-inflammatory and pain-relieving properties make it a valuable candidate for further investigation and development of new drugs and treatments.
Used in Medical Research:
In the field of medical research, 3-OXO-3-(4-PHENOXYPHENYL)PROPIONIC ACID METHYL ESTER is utilized for exploring its potential applications in the management of various inflammatory conditions. Its molecular structure and properties provide a foundation for understanding its mechanism of action and optimizing its therapeutic potential.
Overall, 3-OXO-3-(4-PHENOXYPHENYL)PROPIONIC ACID METHYL ESTER is a promising chemical compound with significant potential in the pharmaceutical and medical research industries, offering new avenues for the development of effective treatments for inflammatory disorders.

Upstream product

• 5031-78-7 4-phenoxyacetophenone 
• 616-38-6 carbonic acid dimethyl ester 

Downstream Products

• 1421312-34-6 4-hydroxy-1-methyl-7-phenoxyisoquinolinyl-3-carboxylic acid methyl ester 

Relevant academic research and scientific papers

SUBSTITUTED IMIDAZOLECARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS

The disclosure relates to a series of substituted imidazolecarboxamide compounds of formula I as BTK (Bruton's Tyrosine Kinase) inhibitors, and the methods of using the same for the treatment of autoimmune disease, inflammatory disease, cancer and potenti

Structure-activity relationship investigation for imidazopyrazole-3-carboxamide derivatives as novel selective inhibitors of Bruton's tyrosine kinase

BTK (Bruton's tyrosine kinase) inhibitors are the most promising drugs for the treatment of hematological tumors. A high selectivity of BTK inhibitors ensures reduced side effects from off-targeting. Accordingly, here, based on Zanubrutinib, we designed a

The guareschi pyridine scaffold as a valuable platform for the identification of selective PI3K inhibitors

A novel series of 4-aryl-3-cyano-2-(3-hydroxyphenyl)-6-morpholino-pyridines have been designed as potential phosphatidylinositol-3-kinase (PI3K) inhibitors. The compounds have been synthesized using the Guareschi reaction to prepare the key 4-aryl- 3-cyano-2,6-dihydroxypyridine intermediate. A different selectivity according to the nature of the aryl group has been observed. Compound 9b is a selective inhibitor against the PI3Kα isoform, maintaining a good inhibitory activity. Docking studies were also performed in order to rationalize its profile of selectivity.

THIAZOLES, IMIDAZOLES, AND PYRAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES

The present invention relates to compounds useful as inhibitors of protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and the compositions in the treatment of

COMPOUNDS USEFUL AS AICARFT INHIBITORS

Compounds of the formula:(where R1, R2 and R3 are defined in the specification) are inhibitors of AICARFT. These compounds, as well as their pharmaceutically acceptable salts, solvents, prodrugs, and pharmaceutically active metabolites, are useful in pharmaceutical compositions for treating diseases such as cancer.